107 related articles for article (PubMed ID: 6796187)
21. Prostaglandins I2 and E1 reduce rabbit and human platelet adherence without inhibiting serotonin release from adherent platelets.
Cazenave JP; Dejana E; Kinlough-Rathbone RL; Richardson M; Packham MA; Mustard JF
Thromb Res; 1979; 15(1-2):273-9. PubMed ID: 384598
[No Abstract] [Full Text] [Related]
22. Prostaglandin E-1 and peripheral vascular disease.
Kyle V; Hazleman B
Lancet; 1983 Jul; 2(8344):282. PubMed ID: 6135105
[No Abstract] [Full Text] [Related]
23. Recount of prostaglandin E1 therapy in a patient with Raynaud's phenomenon.
DiGiovanni RL; Littlefield JM; Good RG
J Am Osteopath Assoc; 1995 Oct; 95(10):572. PubMed ID: 8557544
[No Abstract] [Full Text] [Related]
24. Effects of Prostaglandin E1, prostacyclin, and tolazoline on elevated pulmonary vascular resistance in neonatal swine.
Starling MB; Neutze JM; Elliott RL
Adv Prostaglandin Thromboxane Res; 1980; 7():755-7. PubMed ID: 6989202
[No Abstract] [Full Text] [Related]
25. The effect of prostaglandins I2, E1, E2 and dibutyryl cyclic AMP on the cytoplasmic spreading of rat osteoclasts.
Chambers TJ; Fuller K; Athanasou NA
Br J Exp Pathol; 1984 Oct; 65(5):557-66. PubMed ID: 6091728
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment of Raynaud's phenomenon with limaprost, an oral prostaglandin E1 analogue.
Tsukamoto H; Nagasawa K
Br J Rheumatol; 1991 Aug; 30(4):317. PubMed ID: 1863837
[No Abstract] [Full Text] [Related]
27. Raynaud's syndrome: current trends.
Belch JJ; Sturrock RD
Br J Rheumatol; 1983 Feb; 22(1):50-5. PubMed ID: 6337664
[No Abstract] [Full Text] [Related]
28. Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis.
Gordon D; Henderson DC; Westwick J
Br J Pharmacol; 1979 Sep; 67(1):17-22. PubMed ID: 387146
[TBL] [Abstract][Full Text] [Related]
29. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
[No Abstract] [Full Text] [Related]
30. Prostacyclin and prostaglandin E2 selectively antagonize responses of human isolated myometrium to excitatory prostaglandins [proceedings].
Bennett A; Sanger GJ
J Physiol; 1979 Jul; 292():36P-37P. PubMed ID: 385831
[No Abstract] [Full Text] [Related]
31. Actions of prostaglandins I2 and E2 on coronary occlusion-induced arrhythmias in the rat.
Au TL; Collins GA; Harvie CJ; Walker MJ
Adv Prostaglandin Thromboxane Res; 1980; 7():647-9. PubMed ID: 6989191
[No Abstract] [Full Text] [Related]
32. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
[TBL] [Abstract][Full Text] [Related]
33. [Effect of prostacyclin on blood circulatory indices in the rat].
Markov KhM; Pinelis VG
Patol Fiziol Eksp Ter; 1982; (2):35-8. PubMed ID: 7045784
[No Abstract] [Full Text] [Related]
34. Prostaglandins release plasma 'reciprocal coupling factor' in anaesthetized rats.
Hoult JR; Moore PK
Br J Pharmacol; 1981 Oct; 74(2):485-7. PubMed ID: 7032632
[TBL] [Abstract][Full Text] [Related]
35. Interactions of verapamil and prostaglandins F2alpha, D2, I2, A1 and E1 in isolated hearts and coronary preparations.
Rettkowski W; Mentz P; Förster W
Acta Biol Med Ger; 1978; 37(5-6):807-9. PubMed ID: 369258
[No Abstract] [Full Text] [Related]
36. Epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome.
Kahan A; Weber S; Amor B; Menkes CJ
Lancet; 1983 Mar; 1(8323):538. PubMed ID: 6131248
[No Abstract] [Full Text] [Related]
37. [Effect of prostaglandins on the conductivity of model membranes].
Gabrielian ES; Badzhinian SA
Biull Eksp Biol Med; 1981 Oct; 91(10):439-40. PubMed ID: 7032621
[TBL] [Abstract][Full Text] [Related]
38. Regulation of human lymph contractility by prostaglandins and thromboxane.
Sinzinger H; Kaliman J; Mannheimer E
Lymphology; 1984 Jun; 17(2):43-5. PubMed ID: 6381904
[TBL] [Abstract][Full Text] [Related]
39. Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.
Sinzinger H; O'Grady J; Fitscha P; Kaliman J
N Engl J Med; 1984 Oct; 311(16):1052. PubMed ID: 6384781
[No Abstract] [Full Text] [Related]
40. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1.
Chambers TJ; Ali NN
J Pathol; 1983 Mar; 139(3):383-97. PubMed ID: 6339702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
